公司概覽
業務類別 --
業務概覽 FOXO Technologies Inc is a healthcare services and technology company. It currently operates four synergistic divisions: (i) a rural hospital division; (ii) a mental and behavioral health division; (iii) an information, data and biospecimen sourcing division; and (iv) an epigenetics diagnostics and interpretation division. The Company manages and classifies its business into three reportable business segments: (i) Healthcare, (ii) Life Science Services and (iii) Labs. Myrtle, RCHI and SCCH operate under the Healthcare segment and Vector operates under the Life Science Services segment. The company generates majority of its revenue from Healthcare segment. It includes RCHI's hospital, BSF, has 25 inpatient beds, and a 24/7 emergency department and provides ancillary services.
公司地址 477 South Rosemary Avenue, Suite 224, West Palm Beach, FL, USA, 33401
電話號碼 +1 612 800-0059
傳真號碼 --
公司網頁 https://foxotechnologies.com
員工數量 192
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Seamus Lagan Director, Chief Executive Officer and Interim Chief Financial Officer and Principal Accounting Officer -- 13/06/2025
Mr. Mark White Director; Chief Executive Officer of FOXO Labs Inc. -- 15/04/2025
 
董事會成員
董事會 職務 更新日期
Mr. Seamus Lagan Director, Chief Executive Officer and Interim Chief Financial Officer and Principal Accounting Officer 13/06/2025
Mr. Trevor Langley Chairman of the Board 15/04/2025
Mr. Bret Barnes Independent Director 15/04/2025
Mr. Mark White Director; Chief Executive Officer of FOXO Labs Inc. 15/04/2025
Mr. Francis Colt deWolf, III Independent Director 15/04/2025
 
所屬ETF (更新日期: 30/07/2026 07:30)
代號 名稱 佔比% ▼ 持有日期
BRWSaba Capital Income & Opportunities Fund0.34%31/10/2021
RIVRiverNorth Opportunities0.25%30/04/2022
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.